Kenvue Inc. Common Stock vs Revolution Medicines Inc. Common Stock — how do they compare? Kenvue Inc. Common Stock trades at $17.64 (market cap $34.06B), while Revolution Medicines Inc. Common Stock trades at $189.32 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is the larger of the two by market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals.
| KVUE | RVMD | |
|---|---|---|
Market Cap | $34.06B | $40.32B |
Volume | 23,267,228 | 4,855,734 |
Sector | Consumer Staples | Health |
52-Week High | $19.83 | $221.15 |
52-Week Low | $14.11 | $47.50 |
Enterprise Value | $41.56B | $37.02B |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 0 Days |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →